Trade VALN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Valneva SE American Depositary Shares (VALN) is trading at US$6.43, down 1.98% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$659.97M. Over the past 52 weeks, VALN has traded between US$4.75 and US$12.23. On Syfe you can trade VALN with $0 commission and add it to your watchlist.
| Previous close | US$6.56 |
|---|---|
| Market cap | US$659.97M |
| P/E ratio | 75.69 |
| 52-week range | US$4.75 – US$12.23 |
| Volume | 22.29K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Valneva SE American Depositary Shares
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. It currently provides three proprietary travel vaccines: IXIARO, DUKORAL, and IXCHIQ. The IXIARO is an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis in adults, adolescents, children, and infants aged two months and older. The DUKORAL is a drinkable vaccine that helps prevent diarrhea caused by heat-labile toxin-producing ETEC, as well as cholera. The IXCHIQ is a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also offers additional vaccines, including VLA1553, VLA15, VLA160, VLA200, VLA1601 and others. Valneva was founded on May 28, 2013 and is headquartered in Saint-Herblain, France.
Year: 2021
Stay on top of VALN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
